PinnyPeptide

Ovagen vs Pancragen

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Ovagen

Bioregulators

Khavinson short peptide bioregulator targeting hepatocytes and liver function.

Peptide B

Pancragen

Bioregulators

Khavinson short peptide bioregulator targeting pancreatic tissue and glucose metabolism.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Ovagen effects

  • Reported normalization of elevated liver enzymes
  • Improvement in synthetic liver function markers
  • Support of hepatocyte regeneration
  • Anti-inflammatory effects in chronic liver disease
  • Modulation of hepatic gene expression

Pancragen effects

  • Reported support of residual β-cell function
  • Improvements in fasting glucose and HbA1c (Russian observational)
  • Support of exocrine pancreatic function
  • Improvement in digestion in pancreatic insufficiency
  • Modulation of pancreatic gene expression

Ovagen side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation

Pancragen side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation
  • Should not substitute for proven diabetes therapies

Ovagen dosing ranges

Hepatic support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Pancragen dosing ranges

Pancreatic support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Full Ovagen guide → Full Pancragen guide →

Ovagen vs Pancragen — common questions

What is the difference between Ovagen and Pancragen?

Ovagen: Khavinson short peptide bioregulator targeting hepatocytes and liver function. Typical dose 1,000-5,000 mcg. Pancragen: Khavinson short peptide bioregulator targeting pancreatic tissue and glucose metabolism. Typical dose 1,000-5,000 mcg. Both fall under the Bioregulators category.

Can you stack Ovagen and Pancragen?

Stacking Ovagen with Pancragen is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Ovagen or Pancragen?

Ovagen is typically dosed: Once daily (SubQ) or sublingual for Hepatic support. Pancragen is typically dosed: Once daily (SubQ) or sublingual for Pancreatic support.

Are Ovagen and Pancragen FDA approved?

Ovagen: Not FDA approved. Pancragen: Not FDA approved.

Related peptide comparisons

bronchogen vs ovagencardiogen vs ovagencartalax vs ovagencortagen vs ovagencrystagen vs ovagenbronchogen vs pancragen

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free